Solution and cell studies were performed to ascertain why individuals with hemoglobin (Hb) SC have disease whereas those with Hb AS do not. The polymerization of deoxygenated mixtures containing sickle cell Hb (Hb S; a2P26GIu-VaI) and Hb C (a2f326GIu Lys) was investigated by measurements of delay times and solubilities. In mixtures containing more than 40% Hb S. polymerization takes place by the same mechanism as in solutions of Hb S alone, with no evidence for independent crystallization of Hb C. A detailed comparison of Hb S/Hb C and Hb S/Hb A mixtures with identical concentrations and proportions of Hb S show that there is no significant difference in the tendency of Hb C and Hb A to copolymerize with Hb S. In 50:50 Hb S/ Hb C mixtures, polymerization is about 15 times more rapid than in 40:60 Hb S/Hb A mixtures at the same total Hb concentration. Measurements on density-fractionated erythrocytes show that SC cells contain a higher total Hb concentration and a more uniform distribution, of reticulocytes compared to normal (AA) or sickle trait (AS) cells. The concentration distribution for C trait (AC) cells is much closer to that of SC cells than to AS or AA cells. It appears, therefore, that the presence of Hb C results in the SC cell beginning its life-with an abnormally high Hb concentration. From these findings we conclude that both the larger proportion of Hb S and the higher intracellular Hb concentration contribute to the pathogenesis of Hb SC disease.Hemoglobin (Hb) SC disease is one of the most prevalent ofthe sickling disorders. Patients with Hb SC disease are double (or compound) heterozygotes. They inherit a s35-globin gene from one parent and a I3C-globin gene from the other. The erythrocytes from these individuals usually contain about 50% sickle cell Hb (Hb S) (a2p26 Glu-Val), 50% Hb C (a2026 Glu-*Lys) and no Hb A (a2 326 Glu). In contrast, the most frequently observed composition in the more common heterozygous state, sickle trait (AS), is 40% Hb S and 60% Hb A. Another important difference is that the mean intracellular Hb concentration (MCHC) is higher for SC erythrocytes compared to either AS cells or cells from patients homozygous for the PS gene (1).SC patients have a life-long hemolytic anemia of moderate severity and develop vaso-occlusive episodes and organ damage similar to that encountered in homozygous (SS) sickle cell anemia (1, 2). Why do SC individuals have significant clinical abnormalities, while sickle trait is essentially benign? It is generally assumed that the clinical manifestations of SC disease reflect more extensive formation of intracellular polymer compared to AS erythrocytes subjected to a comparable degree of deoxygenation (2). This is based on early in vitro measurements ofcell morphology and blood viscosity (3, 4). More recent work, including kinetic (5-7) and NMR studies (8-10), is consistent with these findings.Three factors could contribute to the increased polymerization in SC cells in vitro-the higher proportion of Hb S, the higher total intracellula...